isoxazoles has been researched along with Cytomegalovirus in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 16 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L | 1 |
| Grose, C; Jadhav, A; Meier, JL; Shrimp, JH; Thorpe, AL; Widmeyer, SRT | 1 |
| Bollavarapu, R; Das, P; Hamme, AT; Hasan, MH; Mitra, D; Raucher, D; Tandon, R; Valente, EJ | 1 |
| Chan, LK; Dunn, JH; Levi, ME; Mandava, N; Olson, JL; Weinberg, A | 1 |
| Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ | 1 |
| Hsieh, SC; Lu, CH; Tsai, JH; Wu, MZ; Yu, CL | 1 |
| Boeckh, M; Murphy, WJ; Peggs, KS | 1 |
| Andrei, G; Kokosza, K; Piotrowska, DG; Schols, D; Snoeck, R | 1 |
| Goldstein, DA; Jumroendararasame, C; Minkus, CL; Pursell, K; Rifkin, LM | 1 |
| Alioto, D; Ferrari Piquero, JM; Gómez Valbuena, I; Serrano Garrote, O | 1 |
| Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E | 1 |
| Bright, PD; Donati, M; Gompels, M; Johnston, S | 1 |
| Barbera, RF; Chuluyan, JC; Colombini, AC; Orden, AO | 1 |
| Chacko, B; John, GT | 1 |
| Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H | 1 |
| Hua-Song, Z; Qi, R; Xiao-Feng, Z | 1 |
| Andreoni, KA; Evers, DL; Huang, ES; Huong, SM; Wang, X | 1 |
| Chong, AS; Knight, DA; Meister, GT; Shen, J; Waldman, WJ; Williams, JW; Zeng, H | 1 |
| Chan, LK; Levi, ME; Mandava, N; Olson, JL; Weinberg, A | 1 |
| Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P | 1 |
| Avery, RK; Mossad, SB | 1 |
| Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Waldman, WJ; Williams, JW | 1 |
| Blinder, L; Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Shen, J; Waldman, WJ; Williams, JW | 1 |
| Keast, D; Vasquez, AR | 1 |
3 review(s) available for isoxazoles and Cytomegalovirus
| Article | Year |
|---|---|
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load | 2013 |
Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies.
Topics: Acetates; Adoptive Transfer; Animals; Antiviral Agents; Benzimidazoles; Cell- and Tissue-Based Therapy; Clinical Trials, Phase III as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Killer Cells, Natural; Leflunomide; Mice; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes | 2015 |
Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review.
Topics: Administration, Oral; Antiviral Agents; Benzimidazoles; Blood; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Ribonucleosides; Sputum; Time Factors | 2017 |
1 trial(s) available for isoxazoles and Cytomegalovirus
| Article | Year |
|---|---|
Leflunomide for cytomegalovirus: bench to bedside.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Humans; Isoxazoles; Leflunomide; Transplantation | 2012 |
20 other study(ies) available for isoxazoles and Cytomegalovirus
| Article | Year |
|---|---|
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors | 2017 |
Chemical Control of a CRISPR-Cas9 Acetyltransferase.
Topics: Acetylation; Azepines; Benzimidazoles; Capsid Proteins; CRISPR-Associated Protein 9; CRISPR-Associated Proteins; CRISPR-Cas Systems; Cytomegalovirus; E1A-Associated p300 Protein; Enzyme Inhibitors; HEK293 Cells; Humans; Hydantoins; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Protein Domains; Recombinant Fusion Proteins; RNA, Guide, Kinetoplastida; Spiro Compounds; Streptococcus pyogenes; Transcription, Genetic; Transcriptional Activation; Triazoles | 2018 |
Design, Synthesis, and Preliminary Studies of Spiro-isoxazoline-peroxides against Human Cytomegalovirus and Glioblastoma ∥.
Topics: Antineoplastic Agents; Antiviral Agents; Brain Neoplasms; Cell Proliferation; Cytomegalovirus; Drug Design; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Peroxides; Spiro Compounds; Tumor Cells, Cultured | 2019 |
Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
Topics: Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Viremia | 2013 |
Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects?
Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Isoxazoles; Leflunomide; Viral Load | 2015 |
Design, antiviral and cytostatic properties of isoxazolidine-containing amonafide analogues.
Topics: Acrylamides; Adenine; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Survival; Cycloaddition Reaction; Cytomegalovirus; Cytostatic Agents; Drug Design; Enterovirus; Humans; Isoxazoles; Naphthalimides; Nitrogen Oxides; Organophosphonates; Phlebovirus; Simplexvirus; Structure-Activity Relationship; Vaccinia virus | 2015 |
Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.
Topics: Administration, Oral; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Genotype; Humans; Immunosuppressive Agents; Intravitreal Injections; Isoxazoles; Kidney Transplantation; Leflunomide; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Viremia | 2017 |
[Use of leflunomide in a cytomegalovirus infection resistant: a report of a case].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Humans; Isoxazoles; Leflunomide; Off-Label Use; Viral Load; Young Adult | 2016 |
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation | 2016 |
Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.
Topics: Antirheumatic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dermatomyositis; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Middle Aged; Opportunistic Infections; Treatment Outcome | 2012 |
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome | 2012 |
Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus.
Topics: Apoptosis; Cell Proliferation; Cell Shape; Cytomegalovirus; Cytomegalovirus Infections; Embryo, Mammalian; Fibroblasts; Humans; Isoxazoles; Leflunomide; Lung; Time Factors | 2013 |
Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.
Topics: Alkynes; Antiviral Agents; Cell Line; Cytomegalovirus; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Nitriles; Signal Transduction; Viral Plaque Assay; Viral Proteins; Virus Replication | 2005 |
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
Topics: Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Heart; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Lectins, C-Type; Leflunomide; Lung; Rats; Rats, Inbred Lew; Salivary Glands; Spleen; Transplants; Uridine; Viral Proteins | 2006 |
Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Multiple, Viral; Female; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Treatment Outcome | 2006 |
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation | 2007 |
Second look at leflunomide "failure" to control cytomegalovirus infection in the setting of renal failure.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Humans; Isoxazoles; Leflunomide; Renal Insufficiency | 2007 |
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
Topics: Antiviral Agents; Blotting, Northern; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endothelium, Vascular; Fibroblasts; Foscarnet; Gene Expression; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Time Factors; Transcription, Genetic; Umbilical Veins; Viral Proteins; Virus Replication | 1999 |
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.
Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Endothelium, Vascular; Fibroblasts; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Uridine | 1999 |
Inhibition in vitro of the replication of murine cytomegalovirus or reovirus type 3 by the glutamine analogue acivicin.
Topics: 3T3 Cells; Analysis of Variance; Animals; Cell Division; Cytomegalovirus; DNA, Viral; Glutamine; Isoxazoles; Mice; Reoviridae; RNA, Viral; Virus Replication | 1992 |